Saxenda vs Wegovy: Differences, Price, and How to Choose

Saxenda and Wegovy look similar on paper. Same drug class. Same manufacturer. Same basic promise. 

But one requires a daily injection while the other is weekly, and in head-to-head trials, one produced nearly 2.5 times the weight loss.

Here is what you need to know.

Saxenda vs Wegovy: A Quick Overview

‍

What Is Saxenda?

Saxenda contains liraglutide, a GLP-1 receptor agonist that mimics a natural hormone regulating appetite and blood sugar. It slows stomach emptying so you feel full longer and eat less.

FDA-approved in 2014 for adults with a BMI of 30+ (or 27+ with a weight-related condition) and adolescents 12+ with obesity, Saxenda was the first GLP-1 approved specifically for weight loss.

What Is Wegovy?

Wegovy contains semaglutide, which targets the same GLP-1 receptors but stays active in the body far longer than liraglutide. 

That extended duration explains the once-weekly dosing and the stronger weight-loss outcomes observed in clinical trials.

Approved for weight management in 2021, Wegovy has since gained additional FDA approvals for reducing cardiovascular risk in adults with heart disease and obesity, and for treating non-cirrhotic MASH.

Key Differences That Actually Matter

1. Weight Loss Results

The only head-to-head trial made the gap hard to ignore. Over 68 weeks, Saxenda users lost an average of 6.4% of their body weight. While Wegovy users lost 15.8%, nearly twice as much as those on placebo.

So if you weigh 220 pounds, that is the difference between losing 14 pounds and losing 35. 

A higher-dose Wegovy trial (7.2 mg) later increased average weight loss to 21%, or about 46 pounds from the same starting weight.

Both results required diet and exercise. The medications sharpen the effort. They don’t replace it.

2. FDA Approval Scope

Saxenda is approved strictly for weight management. 

Wegovy carries three approvals: 

• Cardiovascular risk reduction.
• Weight management.
• MASH treatment. 

If you have heart disease alongside obesity, Wegovy may offer benefits beyond weight loss alone.

3. Dosing and Administration

Both are subcutaneous injections into the fat layer of the abdomen, thigh, or upper arm. Simple, relatively painless, and designed for home use.

‍

Saxenda uses a multi-dose pen lasting about 6 days at full dose. You attach a new needle before each injection. And inject at the same time daily, with or without food. 

If you miss 3 or more consecutive days, restart at 0.6 mg.

Wegovy uses a single-use prefilled pen. One injection, then dispose. 

If you miss a dose and your next scheduled one is more than 2 days away, take the missed dose right away.

4. Side Effects

Both share a similar side effect profile because they act on the same pathway. Most effects are gastrointestinal and peak during titration:

• Stomach pain
• Constipation
• Headache
• Vomiting
• Diarrhea
• Nausea
• Fatigue

Wegovy may trigger more intense early nausea due to semaglutide's greater potency.

In the STEP 8 trial, 27.6% of Saxenda users discontinued use, compared with 13.5% of Wegovy users.

If full-dose GLP-1 side effects feel overwhelming, microdose GLP-1 injections may offer a gentler starting point.

For either medication, eating smaller meals, staying hydrated, and avoiding high-fat or greasy foods during the titration phase may help reduce nausea.

5. Cost

Both carry a list price of roughly $1,350 per month. But what you actually pay varies widely.

‍

Generic liraglutide (approved late 2025) has made Saxenda the more budget-friendly brand-name GLP-1 at certain pharmacies. 

Wegovy's subscription pricing, meanwhile, may bring monthly costs under $250 for patients who commit to longer plans.

If brand-name pricing remains out of reach, Ivy Rx offers personalized GLP-1 injections starting at $175 per month, with medical evaluation, ongoing support, and medications shipped to your door.

Explore personalized GLP-1 injections at Ivy Rx.

6. Insurance and Coverage

Coverage varies dramatically by plan. 

Saxenda's longer market history gives it an edge on some formularies, and generic liraglutide may further reduce costs. Wegovy often faces stricter prior authorization. 

Many employer plans still exclude weight loss medications entirely, and Medicare Part D generally does not cover them for weight loss. 

Always verify with your insurer before starting treatment.

Safety Considerations

Both medications carry a boxed warning about thyroid C-cell tumors found in rodent studies. 

Whether this risk applies to humans remains unconfirmed. 

Neither medication should be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2.

Other shared concerns include acute pancreatitis, gallbladder problems, and potential kidney effects from dehydration caused by GI side effects.

• Specific to Saxenda: slightly higher hypoglycemia risk (especially if you take diabetes medications) and possible resting heart rate increases.
• Specific to Wegovy: not yet studied in patients with a history of pancreatitis. Providers should evaluate kidney function in patients experiencing persistent nausea or vomiting.

Discuss your complete medical history with a qualified provider before starting either medication. 

Ivy Rx's personalized GLP-1 injection plans include a medical evaluation to help ensure the treatment fits your health profile.

Who Might Choose Saxenda?

Saxenda may suit you better if:

• You prefer daily dosing control: Some people find a daily routine easier to stick with than remembering a weekly injection. The shorter half-life (~13 hours) also means the medication clears your system more quickly if you decide to stop taking it.
• Your insurance covers liraglutide: Saxenda has been on formularies longer, and generic liraglutide may bring your monthly cost well below brand-name alternatives.
• You want to ease into GLP-1 therapy: Because liraglutide is less potent than semaglutide, some providers use it as a starting point for patients new to the drug class.
• You are an adolescent (12+) with obesity: Saxenda has a well-established track record in this age group.

Who Might Choose Wegovy?

Wegovy may suit you better if:

• You want maximum weight loss: Semaglutide delivers roughly 2.5 times the weight loss of liraglutide over the same period. If you have a significant amount of weight to lose, that difference matters.
• You prefer fewer injections: One shot per week versus seven per week may make a real difference in long-term adherence, especially if needle fatigue is a concern.
• You have cardiovascular disease: Wegovy's additional FDA approval for reducing heart attack, stroke, and cardiovascular death risk makes it a more comprehensive option for people who carry those risk factors.
• You prefer a needle-free option: The Wegovy tablet removes the injection requirement entirely, though it requires strict morning timing on an empty stomach.

Who Should Not Take Either?

These medications are not appropriate for everyone. Do not use Saxenda or Wegovy if you:

• Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
• Are pregnant, breastfeeding, or planning pregnancy (stop at least 2 months before a planned pregnancy for Wegovy; 5 weeks for Saxenda).
• Have a known hypersensitivity to semaglutide, liraglutide, or any ingredient in the formulation.
• Are already taking another GLP-1 receptor agonist.

If you take insulin or sulfonylureas for diabetes, your provider may need to adjust those medications before starting treatment to reduce hypoglycemia risk.

Can You Switch Between Them?

Yes, but only with provider guidance.

The doses are not equivalent. Your provider will likely restart you at the lowest dose of the new medication and titrate up again to reduce side effects. 

That means the transition takes time. A few things to keep in mind:

• Direction matters. Switching from Wegovy to Saxenda may slow your weight loss, since liraglutide produces more modest results. Moving from Saxenda to Wegovy, on the other hand, may accelerate outcomes.
• Insurance implications may shift. A plan that covers one medication may not cover the other. Confirm coverage before making the switch.
• Reasons to switch vary. Side effect management, inadequate results, cost changes, or a preference for a different dosing schedule are all valid reasons your provider may support a transition.

The key is working with a provider who understands GLP-1 pharmacokinetics and can adjust your titration accordingly.

Get a Tailored Weight Loss Plan from Ivy Rx

The right medication depends on your health, your budget, and how your body responds.

Ivy Rx provides medical evaluations, ongoing provider support, and personalized GLP-1 injections starting at $175/month. 

No insurance required. Medications shipped to your door.

Start your evaluation with Ivy Rx.

FAQs

Is Saxenda the Same as Wegovy?

No. Both are GLP-1 receptor agonists, but Saxenda uses liraglutide (daily) while Wegovy uses semaglutide (weekly or daily pill). Wegovy generally produces greater weight loss.

When Is Liraglutide Used for Diabetes?

Liraglutide treats type 2 diabetes under the brand name Victoza, at a lower dose than Saxenda. Saxenda itself is approved only for weight management.

Are They Covered by Insurance?

Sometimes. Coverage depends on your plan, employer, and state. Prior authorization is common. Medicare Part D generally does not cover weight loss.

Who Makes Wegovy?

Novo Nordisk, the same company behind Saxenda, Ozempic, and Victoza.

Can I Take Both Together?

No. Combining GLP-1 medications increases the risk of serious side effects. Use only one at a time.

‍